InsiderSignal.AI

InsiderSignal.ai

WVE - Wave Life Sciences Ltd.

Insider Purchase by Gsk Plc (10%)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

2 months ago, Gsk Plc, serving as 10% owner at Wave Life Sciences Ltd. (WVE), purchased 1,470,000 shares at $19.00 per share, for a total transaction value of $27,930,000.00. Following this transaction, Gsk Plc now holds 18,245,691 shares of WVE.

This purchase represents a 9.00% increase in Gsk Plc's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, December 11, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 15, 2025, 4 days after the trade was made.

Wave Life Sciences Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Gsk Plc

10%

GSK plc (GlaxoSmithKline plc), commonly known as GSK, is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is one of the world's largest pharmaceutical companies, focusing on research, development, and manufacturing of medicines, vaccines, and consumer healthcare products.[[2]](https://www.marketbeat.com/stocks/NASDAQ/WVE/insider-trades/)[[8]](https://stockcircle.com/insider-trades/person/gsk-plc) The company operates globally with a strong emphasis on areas such as respiratory diseases, HIV, oncology, and infectious diseases, employing over 70,000 people worldwide. As a major shareholder and 10% owner in Wave Life Sciences Ltd. (WVE), GSK plc recently engaged in significant insider trading activity, purchasing 2,791,930 shares on September 27, 2024, at $8.00 per share for approximately $22.34 million, and an additional 1,470,000 shares on December 11, 2025, for an estimated $27.93 million, increasing its holdings to 18,245,691 shares.[[2]](https://www.marketbeat.com/stocks/NASDAQ/WVE/insider-trades/)[[4]](https://www.quiverquant.com/news/Insider+Purchase:+10%25+owner+at+$WVE+Buys+1,470,000+Shares) GSK is listed among WVE's key insiders alongside executives like CEO Paul Bolno.[[2]](https://www.marketbeat.com/stocks/NASDAQ/WVE/insider-trades/)

View full insider profile →

Trade Price

$19.00

Quantity

1,470,000

Total Value

$27,930,000.00

Shares Owned

18,245,691

Trade Date

Thursday, December 11, 2025

73 days ago

SEC Filing Date

Monday, December 15, 2025

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Wave Life Sciences Ltd.

Company Overview

No company information available
View news mentioning WVE

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/2254874

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime